Research on COVID-19 infection indicates that the pulmonary tissues of persons with respiratory distress syndrome (ARDS) demonstrate elevated levels of insulin-like growth factor 1 (IGF-1), also known as somatomedin C, together with the IGF-1 receptor (IGF-1R) [14]. This evidence concerns the gene IGF1 and acute respiratory distress syndrome.